Adagene(us:ADAG)
1.83
-10.73%
Updated on 2024-12-23
Open:1.96
Close:1.83
High:1.96
Low:1.74
Pre Close:2.05
Volume:56295.00
Amount:105726.52
Turnover:0.10%
Shares:55.34M
MarketCap:101.27M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-03-31 | 17 | 12297346 | 27.85% | 6 | 3 | 2 |
| 2023-12-31 | 12 | 7124603 | 16.15% | 2 | 1 | 2 |
| 2023-09-30 | 11 | 4096719 | 9.35% | 1 | 2 | 2 |
| 2023-06-30 | 12 | 4111294 | 9.38% | 1 | 1 | 4 |
| 2023-03-31 | 11 | 4186071 | 9.56% | 2 | 1 | 2 |
| 2022-12-31 | 11 | 4216842 | 9.75% | 0 | 0 | 5 |
| 2022-09-30 | 15 | 5940279 | 13.68% | 0 | 2 | 8 |
| 2022-06-30 | 19 | 7531358 | 17.34% | 3 | 1 | 9 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Wuxi Apptec Co., Ltd. | 3982902 | 9.02% | -242794 | -5.75% |
| 2024-03-31 | Fil Ltd | 3844836 | 8.71% | 3844836 | |
| 2024-03-31 | Fmr Llc | 1348985 | 3.06% | 1224023 | 979.52% |
| 2024-03-31 | Hsg Holding Ltd | 1343364 | 3.04% | 0 | |
| 2024-03-31 | Artal Group S.A. | 1020000 | 2.31% | 20000 | 2.00% |
| 2024-03-31 | General Atlantic, L.P. | 264000 | 0.60% | 0 | |
| 2024-03-31 | Barclays Plc | 175130 | 0.40% | 175130 | |
| 2024-03-31 | Exome Asset Management Llc | 155383 | 0.35% | 155383 | |
| 2024-03-31 | Morgan Stanley | 85677 | 0.19% | -61044 | -41.60% |
| 2024-03-31 | Prelude Capital Management, Llc | 28620 | 0.06% | 28620 |
About
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Address:Suzhou Industrial Park,No. 218 Xingh Street,4/F, Building C14
Website:http://www.adagene.com
Market Movers